nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—CXCR4—blood vessel—Alzheimer's disease	0.0518	0.273	CbGeAlD
Plerixafor—CXCR4—Binding and entry of HIV virion—CCR5—Alzheimer's disease	0.0377	0.102	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—UBQLN1—Alzheimer's disease	0.031	0.0835	CbGpPWpGaD
Plerixafor—CXCR4—embryo—Alzheimer's disease	0.0309	0.163	CbGeAlD
Plerixafor—CXCR4—forebrain—Alzheimer's disease	0.0273	0.144	CbGeAlD
Plerixafor—CXCR4—telencephalon—Alzheimer's disease	0.0251	0.133	CbGeAlD
Plerixafor—CXCR4—nervous system—Alzheimer's disease	0.0148	0.0783	CbGeAlD
Plerixafor—CXCR4—central nervous system—Alzheimer's disease	0.0143	0.0753	CbGeAlD
Plerixafor—CXCR4—cerebellum—Alzheimer's disease	0.0139	0.0736	CbGeAlD
Plerixafor—CXCR4—Early Phase of HIV Life Cycle—CCR5—Alzheimer's disease	0.0138	0.0373	CbGpPWpGaD
Plerixafor—Upset stomach—Galantamine—Alzheimer's disease	0.0134	0.0305	CcSEcCtD
Plerixafor—CXCR4—brain—Alzheimer's disease	0.0113	0.0598	CbGeAlD
Plerixafor—Upset stomach—Donepezil—Alzheimer's disease	0.0104	0.0237	CcSEcCtD
Plerixafor—Haematoma—Memantine—Alzheimer's disease	0.00985	0.0224	CcSEcCtD
Plerixafor—Haematoma—Rivastigmine—Alzheimer's disease	0.00963	0.0219	CcSEcCtD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—CP—Alzheimer's disease	0.00798	0.0215	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—TF—Alzheimer's disease	0.00679	0.0183	CbGpPWpGaD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—IL1A—Alzheimer's disease	0.00664	0.0179	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—ENO1—Alzheimer's disease	0.00651	0.0176	CbGpPWpGaD
Plerixafor—Inflammation—Rivastigmine—Alzheimer's disease	0.00624	0.0142	CcSEcCtD
Plerixafor—CXCR4—Syndecan-4-mediated signaling events—F2—Alzheimer's disease	0.00613	0.0165	CbGpPWpGaD
Plerixafor—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.00583	0.0133	CcSEcCtD
Plerixafor—CXCR4—CXCR4-mediated signaling events—INPP5D—Alzheimer's disease	0.00566	0.0153	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—PYY—Alzheimer's disease	0.00561	0.0151	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—IGF2—Alzheimer's disease	0.00558	0.0151	CbGpPWpGaD
Plerixafor—Abdominal discomfort—Galantamine—Alzheimer's disease	0.00529	0.012	CcSEcCtD
Plerixafor—CXCR4—CXCR4-mediated signaling events—PTK2B—Alzheimer's disease	0.00526	0.0142	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—MEF2C—Alzheimer's disease	0.00513	0.0138	CbGpPWpGaD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—NOTCH1—Alzheimer's disease	0.00502	0.0135	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—HMOX1—Alzheimer's disease	0.00475	0.0128	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—PYY—Alzheimer's disease	0.00473	0.0128	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—PLCB1—Alzheimer's disease	0.00471	0.0127	CbGpPWpGaD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCR5—Alzheimer's disease	0.00456	0.0123	CbGpPWpGaD
Plerixafor—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.00452	0.0103	CcSEcCtD
Plerixafor—Haemoglobin—Galantamine—Alzheimer's disease	0.00444	0.0101	CcSEcCtD
Plerixafor—Haemorrhage—Galantamine—Alzheimer's disease	0.00442	0.01	CcSEcCtD
Plerixafor—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00434	0.00987	CcSEcCtD
Plerixafor—Abdominal distension—Donepezil—Alzheimer's disease	0.00431	0.00979	CcSEcCtD
Plerixafor—CXCR4—S1P3 pathway—VEGFA—Alzheimer's disease	0.00427	0.0115	CbGpPWpGaD
Plerixafor—Orthostatic hypotension—Memantine—Alzheimer's disease	0.0041	0.00933	CcSEcCtD
Plerixafor—Abdominal discomfort—Donepezil—Alzheimer's disease	0.0041	0.00932	CcSEcCtD
Plerixafor—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.00401	0.00913	CcSEcCtD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—NOTCH1—Alzheimer's disease	0.004	0.0108	CbGpPWpGaD
Plerixafor—Immune system disorder—Galantamine—Alzheimer's disease	0.00399	0.00907	CcSEcCtD
Plerixafor—CXCR4—Peptide ligand-binding receptors—GAL—Alzheimer's disease	0.00389	0.0105	CbGpPWpGaD
Plerixafor—Mental disorder—Galantamine—Alzheimer's disease	0.00387	0.0088	CcSEcCtD
Plerixafor—Flatulence—Galantamine—Alzheimer's disease	0.00379	0.00862	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—PYY—Alzheimer's disease	0.00376	0.0101	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—GSK3B—Alzheimer's disease	0.00376	0.0101	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—INS—Alzheimer's disease	0.00371	0.01	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—HTR6—Alzheimer's disease	0.00367	0.00988	CbGpPWpGaD
Plerixafor—CXCR4—Peptide GPCRs—CCR5—Alzheimer's disease	0.00365	0.00985	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—LEP—Alzheimer's disease	0.00364	0.00982	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—IGF1—Alzheimer's disease	0.00359	0.00967	CbGpPWpGaD
Plerixafor—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00357	0.00811	CcSEcCtD
Plerixafor—CXCR4—Chemokine receptors bind chemokines—CCL2—Alzheimer's disease	0.00349	0.00941	CbGpPWpGaD
Plerixafor—Malaise—Galantamine—Alzheimer's disease	0.00347	0.00788	CcSEcCtD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—IL1B—Alzheimer's disease	0.00346	0.00934	CbGpPWpGaD
Plerixafor—Syncope—Galantamine—Alzheimer's disease	0.00345	0.00784	CcSEcCtD
Plerixafor—Haemoglobin—Donepezil—Alzheimer's disease	0.00344	0.00782	CcSEcCtD
Plerixafor—Haemorrhage—Donepezil—Alzheimer's disease	0.00342	0.00778	CcSEcCtD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—NOS2—Alzheimer's disease	0.00339	0.00915	CbGpPWpGaD
Plerixafor—Loss of consciousness—Galantamine—Alzheimer's disease	0.00338	0.00768	CcSEcCtD
Plerixafor—CXCR4—G alpha (i) signalling events—GAL—Alzheimer's disease	0.00328	0.00885	CbGpPWpGaD
Plerixafor—Arthralgia—Galantamine—Alzheimer's disease	0.00327	0.00744	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00325	0.00739	CcSEcCtD
Plerixafor—Discomfort—Galantamine—Alzheimer's disease	0.00323	0.00735	CcSEcCtD
Plerixafor—Dry mouth—Galantamine—Alzheimer's disease	0.0032	0.00728	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	0.00314	0.00847	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—CREB1—Alzheimer's disease	0.00313	0.00843	CbGpPWpGaD
Plerixafor—Haemoglobin—Memantine—Alzheimer's disease	0.00312	0.0071	CcSEcCtD
Plerixafor—Haemorrhage—Memantine—Alzheimer's disease	0.00311	0.00707	CcSEcCtD
Plerixafor—Shock—Galantamine—Alzheimer's disease	0.00309	0.00702	CcSEcCtD
Plerixafor—Nervous system disorder—Galantamine—Alzheimer's disease	0.00308	0.007	CcSEcCtD
Plerixafor—Haemoglobin—Rivastigmine—Alzheimer's disease	0.00306	0.00695	CcSEcCtD
Plerixafor—CXCR4—Peptide ligand-binding receptors—NPY—Alzheimer's disease	0.00305	0.00824	CbGpPWpGaD
Plerixafor—Connective tissue disorder—Memantine—Alzheimer's disease	0.00305	0.00694	CcSEcCtD
Plerixafor—Skin disorder—Galantamine—Alzheimer's disease	0.00305	0.00693	CcSEcCtD
Plerixafor—Haemorrhage—Rivastigmine—Alzheimer's disease	0.00304	0.00691	CcSEcCtD
Plerixafor—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00303	0.0069	CcSEcCtD
Plerixafor—Mental disorder—Donepezil—Alzheimer's disease	0.003	0.00682	CcSEcCtD
Plerixafor—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00299	0.00679	CcSEcCtD
Plerixafor—Erythema—Donepezil—Alzheimer's disease	0.00298	0.00678	CcSEcCtD
Plerixafor—Flatulence—Donepezil—Alzheimer's disease	0.00294	0.00668	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—PYY—Alzheimer's disease	0.00287	0.00773	CbGpPWpGaD
Plerixafor—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00286	0.0065	CcSEcCtD
Plerixafor—Insomnia—Galantamine—Alzheimer's disease	0.00284	0.00645	CcSEcCtD
Plerixafor—Paraesthesia—Galantamine—Alzheimer's disease	0.00282	0.00641	CcSEcCtD
Plerixafor—Immune system disorder—Memantine—Alzheimer's disease	0.00281	0.00638	CcSEcCtD
Plerixafor—CXCR4—Peptide ligand-binding receptors—NPS—Alzheimer's disease	0.00279	0.00753	CbGpPWpGaD
Plerixafor—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00276	0.00629	CcSEcCtD
Plerixafor—Dyspepsia—Galantamine—Alzheimer's disease	0.00276	0.00628	CcSEcCtD
Plerixafor—CXCR4—S1P3 pathway—AKT1—Alzheimer's disease	0.00273	0.00735	CbGpPWpGaD
Plerixafor—Mental disorder—Memantine—Alzheimer's disease	0.00272	0.00619	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00271	0.00616	CcSEcCtD
Plerixafor—Fatigue—Galantamine—Alzheimer's disease	0.00271	0.00615	CcSEcCtD
Plerixafor—Malaise—Donepezil—Alzheimer's disease	0.00269	0.00611	CcSEcCtD
Plerixafor—Constipation—Galantamine—Alzheimer's disease	0.00268	0.0061	CcSEcCtD
Plerixafor—Syncope—Donepezil—Alzheimer's disease	0.00267	0.00608	CcSEcCtD
Plerixafor—Flatulence—Memantine—Alzheimer's disease	0.00267	0.00606	CcSEcCtD
Plerixafor—CXCR4—Peptide ligand-binding receptors—SST—Alzheimer's disease	0.00266	0.00719	CbGpPWpGaD
Plerixafor—Mental disorder—Rivastigmine—Alzheimer's disease	0.00266	0.00606	CcSEcCtD
Plerixafor—Erythema—Rivastigmine—Alzheimer's disease	0.00265	0.00602	CcSEcCtD
Plerixafor—Loss of consciousness—Donepezil—Alzheimer's disease	0.00262	0.00596	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	0.00261	0.00703	CbGpPWpGaD
Plerixafor—Flatulence—Rivastigmine—Alzheimer's disease	0.00261	0.00593	CcSEcCtD
Plerixafor—CXCR4—Peptide ligand-binding receptors—APP—Alzheimer's disease	0.0026	0.007	CbGpPWpGaD
Plerixafor—Feeling abnormal—Galantamine—Alzheimer's disease	0.00259	0.00588	CcSEcCtD
Plerixafor—CXCR4—G alpha (i) signalling events—NPY—Alzheimer's disease	0.00258	0.00695	CbGpPWpGaD
Plerixafor—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00257	0.00583	CcSEcCtD
Plerixafor—Arthralgia—Donepezil—Alzheimer's disease	0.00254	0.00577	CcSEcCtD
Plerixafor—Ill-defined disorder—Memantine—Alzheimer's disease	0.00251	0.00571	CcSEcCtD
Plerixafor—Discomfort—Donepezil—Alzheimer's disease	0.00251	0.0057	CcSEcCtD
Plerixafor—Dry mouth—Donepezil—Alzheimer's disease	0.00248	0.00564	CcSEcCtD
Plerixafor—Abdominal pain—Galantamine—Alzheimer's disease	0.00248	0.00564	CcSEcCtD
Plerixafor—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00246	0.00558	CcSEcCtD
Plerixafor—Malaise—Memantine—Alzheimer's disease	0.00244	0.00555	CcSEcCtD
Plerixafor—Syncope—Memantine—Alzheimer's disease	0.00243	0.00552	CcSEcCtD
Plerixafor—Shock—Donepezil—Alzheimer's disease	0.00239	0.00544	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—HTR6—Alzheimer's disease	0.00239	0.00645	CbGpPWpGaD
Plerixafor—Malaise—Rivastigmine—Alzheimer's disease	0.00239	0.00543	CcSEcCtD
Plerixafor—Nervous system disorder—Donepezil—Alzheimer's disease	0.00238	0.00542	CcSEcCtD
Plerixafor—Loss of consciousness—Memantine—Alzheimer's disease	0.00238	0.00541	CcSEcCtD
Plerixafor—Syncope—Rivastigmine—Alzheimer's disease	0.00237	0.0054	CcSEcCtD
Plerixafor—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00235	0.00535	CcSEcCtD
Plerixafor—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00233	0.00529	CcSEcCtD
Plerixafor—Hypersensitivity—Galantamine—Alzheimer's disease	0.00231	0.00526	CcSEcCtD
Plerixafor—Arthralgia—Memantine—Alzheimer's disease	0.0023	0.00524	CcSEcCtD
Plerixafor—Discomfort—Memantine—Alzheimer's disease	0.00228	0.00517	CcSEcCtD
Plerixafor—Arthralgia—Rivastigmine—Alzheimer's disease	0.00225	0.00512	CcSEcCtD
Plerixafor—Dry mouth—Memantine—Alzheimer's disease	0.00225	0.00512	CcSEcCtD
Plerixafor—Asthenia—Galantamine—Alzheimer's disease	0.00225	0.00512	CcSEcCtD
Plerixafor—CXCR4—G alpha (i) signalling events—SST—Alzheimer's disease	0.00225	0.00606	CbGpPWpGaD
Plerixafor—CXCR4—HIV Life Cycle—CCR5—Alzheimer's disease	0.00224	0.00605	CbGpPWpGaD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00224	0.00509	CcSEcCtD
Plerixafor—Discomfort—Rivastigmine—Alzheimer's disease	0.00223	0.00506	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00222	0.00504	CcSEcCtD
Plerixafor—Dry mouth—Rivastigmine—Alzheimer's disease	0.0022	0.00501	CcSEcCtD
Plerixafor—Insomnia—Donepezil—Alzheimer's disease	0.0022	0.005	CcSEcCtD
Plerixafor—CXCR4—G alpha (i) signalling events—APP—Alzheimer's disease	0.00219	0.00591	CbGpPWpGaD
Plerixafor—Paraesthesia—Donepezil—Alzheimer's disease	0.00218	0.00497	CcSEcCtD
Plerixafor—Shock—Memantine—Alzheimer's disease	0.00217	0.00494	CcSEcCtD
Plerixafor—Dyspnoea—Donepezil—Alzheimer's disease	0.00217	0.00493	CcSEcCtD
Plerixafor—Nervous system disorder—Memantine—Alzheimer's disease	0.00217	0.00492	CcSEcCtD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—TGFB1—Alzheimer's disease	0.00215	0.0058	CbGpPWpGaD
Plerixafor—Diarrhoea—Galantamine—Alzheimer's disease	0.00215	0.00488	CcSEcCtD
Plerixafor—Skin disorder—Memantine—Alzheimer's disease	0.00214	0.00488	CcSEcCtD
Plerixafor—Dyspepsia—Donepezil—Alzheimer's disease	0.00214	0.00487	CcSEcCtD
Plerixafor—Hyperhidrosis—Memantine—Alzheimer's disease	0.00213	0.00485	CcSEcCtD
Plerixafor—Shock—Rivastigmine—Alzheimer's disease	0.00213	0.00483	CcSEcCtD
Plerixafor—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00212	0.00482	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.0021	0.00477	CcSEcCtD
Plerixafor—Skin disorder—Rivastigmine—Alzheimer's disease	0.0021	0.00477	CcSEcCtD
Plerixafor—Fatigue—Donepezil—Alzheimer's disease	0.0021	0.00477	CcSEcCtD
Plerixafor—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00209	0.00475	CcSEcCtD
Plerixafor—Pain—Donepezil—Alzheimer's disease	0.00208	0.00473	CcSEcCtD
Plerixafor—Constipation—Donepezil—Alzheimer's disease	0.00208	0.00473	CcSEcCtD
Plerixafor—Dizziness—Galantamine—Alzheimer's disease	0.00208	0.00472	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.00205	0.00552	CbGpPWpGaD
Plerixafor—CXCR4—Disease—ITM2B—Alzheimer's disease	0.00205	0.00552	CbGpPWpGaD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—IL6—Alzheimer's disease	0.00203	0.00547	CbGpPWpGaD
Plerixafor—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00201	0.00457	CcSEcCtD
Plerixafor—Feeling abnormal—Donepezil—Alzheimer's disease	0.002	0.00456	CcSEcCtD
Plerixafor—Insomnia—Memantine—Alzheimer's disease	0.002	0.00454	CcSEcCtD
Plerixafor—Vomiting—Galantamine—Alzheimer's disease	0.002	0.00454	CcSEcCtD
Plerixafor—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00199	0.00452	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—GAL—Alzheimer's disease	0.00199	0.00536	CbGpPWpGaD
Plerixafor—Paraesthesia—Memantine—Alzheimer's disease	0.00198	0.00451	CcSEcCtD
Plerixafor—Rash—Galantamine—Alzheimer's disease	0.00198	0.0045	CcSEcCtD
Plerixafor—Dermatitis—Galantamine—Alzheimer's disease	0.00198	0.00449	CcSEcCtD
Plerixafor—Dyspnoea—Memantine—Alzheimer's disease	0.00197	0.00448	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00197	0.00448	CcSEcCtD
Plerixafor—Headache—Galantamine—Alzheimer's disease	0.00197	0.00447	CcSEcCtD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—VEGFA—Alzheimer's disease	0.00196	0.0053	CbGpPWpGaD
Plerixafor—Insomnia—Rivastigmine—Alzheimer's disease	0.00195	0.00444	CcSEcCtD
Plerixafor—Dyspepsia—Memantine—Alzheimer's disease	0.00194	0.00442	CcSEcCtD
Plerixafor—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00194	0.00441	CcSEcCtD
Plerixafor—Urticaria—Donepezil—Alzheimer's disease	0.00193	0.00439	CcSEcCtD
Plerixafor—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00193	0.00438	CcSEcCtD
Plerixafor—Abdominal pain—Donepezil—Alzheimer's disease	0.00192	0.00437	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00191	0.00433	CcSEcCtD
Plerixafor—Fatigue—Memantine—Alzheimer's disease	0.0019	0.00433	CcSEcCtD
Plerixafor—Dyspepsia—Rivastigmine—Alzheimer's disease	0.0019	0.00432	CcSEcCtD
Plerixafor—Constipation—Memantine—Alzheimer's disease	0.00189	0.00429	CcSEcCtD
Plerixafor—Pain—Memantine—Alzheimer's disease	0.00189	0.00429	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.00187	0.00505	CbGpPWpGaD
Plerixafor—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00186	0.00424	CcSEcCtD
Plerixafor—Nausea—Galantamine—Alzheimer's disease	0.00186	0.00424	CcSEcCtD
Plerixafor—Fatigue—Rivastigmine—Alzheimer's disease	0.00186	0.00423	CcSEcCtD
Plerixafor—Constipation—Rivastigmine—Alzheimer's disease	0.00185	0.0042	CcSEcCtD
Plerixafor—Pain—Rivastigmine—Alzheimer's disease	0.00185	0.0042	CcSEcCtD
Plerixafor—Feeling abnormal—Memantine—Alzheimer's disease	0.00182	0.00414	CcSEcCtD
Plerixafor—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00181	0.00411	CcSEcCtD
Plerixafor—Hypersensitivity—Donepezil—Alzheimer's disease	0.00179	0.00407	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.00179	0.00482	CbGpPWpGaD
Plerixafor—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00178	0.00405	CcSEcCtD
Plerixafor—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00177	0.00402	CcSEcCtD
Plerixafor—Urticaria—Memantine—Alzheimer's disease	0.00175	0.00399	CcSEcCtD
Plerixafor—Abdominal pain—Memantine—Alzheimer's disease	0.00175	0.00397	CcSEcCtD
Plerixafor—Asthenia—Donepezil—Alzheimer's disease	0.00174	0.00397	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.00174	0.0047	CbGpPWpGaD
Plerixafor—Pruritus—Donepezil—Alzheimer's disease	0.00172	0.00391	CcSEcCtD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCR5—Alzheimer's disease	0.00172	0.00463	CbGpPWpGaD
Plerixafor—Urticaria—Rivastigmine—Alzheimer's disease	0.00172	0.0039	CcSEcCtD
Plerixafor—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00171	0.00388	CcSEcCtD
Plerixafor—Diarrhoea—Donepezil—Alzheimer's disease	0.00166	0.00378	CcSEcCtD
Plerixafor—CXCR4—Disease—GAPDHS—Alzheimer's disease	0.00164	0.00441	CbGpPWpGaD
Plerixafor—Hypersensitivity—Memantine—Alzheimer's disease	0.00163	0.0037	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—PYY—Alzheimer's disease	0.00162	0.00437	CbGpPWpGaD
Plerixafor—Dizziness—Donepezil—Alzheimer's disease	0.00161	0.00366	CcSEcCtD
Plerixafor—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00159	0.00362	CcSEcCtD
Plerixafor—Asthenia—Memantine—Alzheimer's disease	0.00158	0.0036	CcSEcCtD
Plerixafor—Pruritus—Memantine—Alzheimer's disease	0.00156	0.00355	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—NPY—Alzheimer's disease	0.00156	0.00421	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—IAPP—Alzheimer's disease	0.00155	0.00418	CbGpPWpGaD
Plerixafor—CXCR4—HIV Infection—CCR5—Alzheimer's disease	0.00155	0.00418	CbGpPWpGaD
Plerixafor—Asthenia—Rivastigmine—Alzheimer's disease	0.00155	0.00352	CcSEcCtD
Plerixafor—Vomiting—Donepezil—Alzheimer's disease	0.00155	0.00352	CcSEcCtD
Plerixafor—Rash—Donepezil—Alzheimer's disease	0.00153	0.00349	CcSEcCtD
Plerixafor—Dermatitis—Donepezil—Alzheimer's disease	0.00153	0.00348	CcSEcCtD
Plerixafor—Pruritus—Rivastigmine—Alzheimer's disease	0.00153	0.00348	CcSEcCtD
Plerixafor—Headache—Donepezil—Alzheimer's disease	0.00152	0.00346	CcSEcCtD
Plerixafor—Diarrhoea—Memantine—Alzheimer's disease	0.00151	0.00344	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—CRH—Alzheimer's disease	0.00151	0.00406	CbGpPWpGaD
Plerixafor—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00148	0.00336	CcSEcCtD
Plerixafor—CXCR4—Peptide ligand-binding receptors—F2—Alzheimer's disease	0.00147	0.00397	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PYY—Alzheimer's disease	0.00147	0.00397	CbGpPWpGaD
Plerixafor—Dizziness—Memantine—Alzheimer's disease	0.00146	0.00332	CcSEcCtD
Plerixafor—CXCR4—G alpha (i) signalling events—CCR5—Alzheimer's disease	0.00145	0.00391	CbGpPWpGaD
Plerixafor—Nausea—Donepezil—Alzheimer's disease	0.00144	0.00328	CcSEcCtD
Plerixafor—Dizziness—Rivastigmine—Alzheimer's disease	0.00143	0.00325	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—NPS—Alzheimer's disease	0.00143	0.00385	CbGpPWpGaD
Plerixafor—CXCR4—Disease—TTR—Alzheimer's disease	0.00142	0.00383	CbGpPWpGaD
Plerixafor—Vomiting—Memantine—Alzheimer's disease	0.0014	0.00319	CcSEcCtD
Plerixafor—Rash—Memantine—Alzheimer's disease	0.00139	0.00317	CcSEcCtD
Plerixafor—Dermatitis—Memantine—Alzheimer's disease	0.00139	0.00316	CcSEcCtD
Plerixafor—Headache—Memantine—Alzheimer's disease	0.00138	0.00315	CcSEcCtD
Plerixafor—Vomiting—Rivastigmine—Alzheimer's disease	0.00137	0.00312	CcSEcCtD
Plerixafor—Rash—Rivastigmine—Alzheimer's disease	0.00136	0.0031	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—SST—Alzheimer's disease	0.00136	0.00367	CbGpPWpGaD
Plerixafor—Dermatitis—Rivastigmine—Alzheimer's disease	0.00136	0.00309	CcSEcCtD
Plerixafor—Headache—Rivastigmine—Alzheimer's disease	0.00135	0.00308	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—HTR6—Alzheimer's disease	0.00135	0.00364	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.00134	0.00363	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—APP—Alzheimer's disease	0.00133	0.00358	CbGpPWpGaD
Plerixafor—CXCR4—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.00132	0.00355	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—CCL2—Alzheimer's disease	0.00131	0.00354	CbGpPWpGaD
Plerixafor—Nausea—Memantine—Alzheimer's disease	0.00131	0.00298	CcSEcCtD
Plerixafor—Nausea—Rivastigmine—Alzheimer's disease	0.00128	0.00292	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—CDK5—Alzheimer's disease	0.00127	0.00344	CbGpPWpGaD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	0.00125	0.00338	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—HTR6—Alzheimer's disease	0.00123	0.00331	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.00115	0.00311	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.00113	0.00304	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GAL—Alzheimer's disease	0.00112	0.00303	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SNCA—Alzheimer's disease	0.00105	0.00284	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—AKT1—Alzheimer's disease	0.00103	0.00279	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GAL—Alzheimer's disease	0.00102	0.00275	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TTR—Alzheimer's disease	0.000994	0.00268	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000988	0.00267	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PSENEN—Alzheimer's disease	0.00094	0.00254	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APH1A—Alzheimer's disease	0.000927	0.0025	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NCSTN—Alzheimer's disease	0.000903	0.00243	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—NPY—Alzheimer's disease	0.000882	0.00238	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000881	0.00238	CbGpPWpGaD
Plerixafor—CXCR4—Disease—LRP1—Alzheimer's disease	0.00088	0.00237	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCR5—Alzheimer's disease	0.000877	0.00237	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000876	0.00236	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PYY—Alzheimer's disease	0.000869	0.00234	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000858	0.00231	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CRH—Alzheimer's disease	0.000851	0.00229	CbGpPWpGaD
Plerixafor—CXCR4—Disease—TPI1—Alzheimer's disease	0.00085	0.00229	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—NPS—Alzheimer's disease	0.000806	0.00217	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—NPY—Alzheimer's disease	0.000801	0.00216	CbGpPWpGaD
Plerixafor—CXCR4—Disease—EIF2AK2—Alzheimer's disease	0.000799	0.00216	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IAPP—Alzheimer's disease	0.000796	0.00215	CbGpPWpGaD
Plerixafor—CXCR4—Disease—GAPDH—Alzheimer's disease	0.000785	0.00212	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CRH—Alzheimer's disease	0.000772	0.00208	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000769	0.00207	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—SST—Alzheimer's disease	0.000769	0.00207	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CDK5—Alzheimer's disease	0.000753	0.00203	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—F2—Alzheimer's disease	0.000753	0.00203	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—APP—Alzheimer's disease	0.00075	0.00202	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PSEN2—Alzheimer's disease	0.000734	0.00198	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—NPS—Alzheimer's disease	0.000732	0.00197	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000729	0.00196	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HTR6—Alzheimer's disease	0.000725	0.00196	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CST3—Alzheimer's disease	0.000718	0.00194	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000707	0.00191	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GAB2—Alzheimer's disease	0.000699	0.00188	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—SST—Alzheimer's disease	0.000699	0.00188	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—APP—Alzheimer's disease	0.000681	0.00184	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IAPP—Alzheimer's disease	0.000671	0.00181	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCL2—Alzheimer's disease	0.000671	0.00181	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PSENEN—Alzheimer's disease	0.000658	0.00178	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APH1A—Alzheimer's disease	0.000649	0.00175	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000642	0.00173	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NCSTN—Alzheimer's disease	0.000632	0.0017	CbGpPWpGaD
Plerixafor—CXCR4—Disease—ENO1—Alzheimer's disease	0.000618	0.00167	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—LRP1—Alzheimer's disease	0.000616	0.00166	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PPP3CA—Alzheimer's disease	0.000615	0.00166	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GFAP—Alzheimer's disease	0.000602	0.00162	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GAL—Alzheimer's disease	0.000602	0.00162	CbGpPWpGaD
Plerixafor—CXCR4—Disease—GAB2—Alzheimer's disease	0.000589	0.00159	CbGpPWpGaD
Plerixafor—CXCR4—Disease—GSK3A—Alzheimer's disease	0.000584	0.00158	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APP—Alzheimer's disease	0.000574	0.00155	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—A2M—Alzheimer's disease	0.000531	0.00143	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000523	0.00141	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PSEN2—Alzheimer's disease	0.000514	0.00139	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000496	0.00134	CbGpPWpGaD
Plerixafor—CXCR4—Disease—ADAM10—Alzheimer's disease	0.000494	0.00133	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000485	0.00131	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000475	0.00128	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NPY—Alzheimer's disease	0.000473	0.00128	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IAPP—Alzheimer's disease	0.00047	0.00127	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CRH—Alzheimer's disease	0.000456	0.00123	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCR5—Alzheimer's disease	0.00045	0.00121	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000441	0.00119	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NPS—Alzheimer's disease	0.000433	0.00117	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PPP3CA—Alzheimer's disease	0.00043	0.00116	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—F2—Alzheimer's disease	0.000425	0.00115	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PTK2B—Alzheimer's disease	0.000424	0.00114	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SST—Alzheimer's disease	0.000413	0.00111	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GAB2—Alzheimer's disease	0.000413	0.00111	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NTRK2—Alzheimer's disease	0.000413	0.00111	CbGpPWpGaD
Plerixafor—CXCR4—Disease—LPL—Alzheimer's disease	0.000412	0.00111	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CALM1—Alzheimer's disease	0.000411	0.00111	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GSK3A—Alzheimer's disease	0.000409	0.0011	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APP—Alzheimer's disease	0.000402	0.00108	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PRKCG—Alzheimer's disease	0.000401	0.00108	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—F2—Alzheimer's disease	0.000386	0.00104	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CCR5—Alzheimer's disease	0.00038	0.00102	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PLCB1—Alzheimer's disease	0.000379	0.00102	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MTHFR—Alzheimer's disease	0.000371	0.001	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NGFR—Alzheimer's disease	0.000354	0.000955	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CREB1—Alzheimer's disease	0.000352	0.000949	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CALM1—Alzheimer's disease	0.000347	0.000935	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ADAM10—Alzheimer's disease	0.000346	0.000933	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APOE—Alzheimer's disease	0.000345	0.000932	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCL2—Alzheimer's disease	0.000344	0.000928	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CAV1—Alzheimer's disease	0.000342	0.000923	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—S100B—Alzheimer's disease	0.000327	0.000882	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NOS2—Alzheimer's disease	0.000322	0.000868	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NOTCH1—Alzheimer's disease	0.000319	0.00086	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IGF2—Alzheimer's disease	0.000311	0.00084	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IGF1R—Alzheimer's disease	0.000301	0.000812	CbGpPWpGaD
Plerixafor—CXCR4—Disease—GSK3B—Alzheimer's disease	0.000299	0.000807	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CREB1—Alzheimer's disease	0.000297	0.0008	CbGpPWpGaD
Plerixafor—CXCR4—Disease—INS—Alzheimer's disease	0.000295	0.000796	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—LPL—Alzheimer's disease	0.000289	0.000778	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MEF2C—Alzheimer's disease	0.000286	0.000771	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PRKCG—Alzheimer's disease	0.000281	0.000757	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NGF—Alzheimer's disease	0.000273	0.000737	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCR5—Alzheimer's disease	0.000266	0.000717	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HTR2A—Alzheimer's disease	0.00026	0.000702	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NOS3—Alzheimer's disease	0.000259	0.000698	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CALM1—Alzheimer's disease	0.000243	0.000655	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—LEP—Alzheimer's disease	0.000242	0.000652	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APOE—Alzheimer's disease	0.000242	0.000652	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CAV1—Alzheimer's disease	0.00024	0.000646	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PTGS2—Alzheimer's disease	0.000237	0.000638	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ESR1—Alzheimer's disease	0.000231	0.000623	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—F2—Alzheimer's disease	0.000228	0.000615	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000223	0.000602	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GSK3B—Alzheimer's disease	0.00021	0.000565	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CREB1—Alzheimer's disease	0.000208	0.00056	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—INS—Alzheimer's disease	0.000207	0.000557	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL2—Alzheimer's disease	0.000203	0.000548	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IGF1—Alzheimer's disease	0.0002	0.000539	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NOS3—Alzheimer's disease	0.000181	0.000489	CbGpPWpGaD
Plerixafor—CXCR4—Disease—TGFB1—Alzheimer's disease	0.000171	0.000462	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—AKT1—Alzheimer's disease	0.000155	0.000419	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CASP3—Alzheimer's disease	0.000154	0.000415	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL6—Alzheimer's disease	0.000153	0.000412	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MAPK8—Alzheimer's disease	0.000141	0.000381	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AKT1—Alzheimer's disease	0.000141	0.00038	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—VEGFA—Alzheimer's disease	0.000131	0.000352	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IL6—Alzheimer's disease	0.000129	0.000348	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TGFB1—Alzheimer's disease	0.00012	0.000323	CbGpPWpGaD
Plerixafor—CXCR4—Disease—AKT1—Alzheimer's disease	0.000119	0.000321	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TP53—Alzheimer's disease	9.87e-05	0.000266	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL6—Alzheimer's disease	9.03e-05	0.000244	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AKT1—Alzheimer's disease	8.33e-05	0.000225	CbGpPWpGaD
